Definitive Contract HHSN268201300026C
Award Date 7/1/13
Potential Completion Date 6/30/18
Potential Value $3.8M
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Birmingham, AL 35294, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to the University of Alabama at Birmingham (UAB) is for the Coronary Artery Risk Development in Young Adults (CARDIA) Study Coordinating Center. The National Heart, Lung, and Blood Institute awarded this $10,195,967.56 definitive, cost-no-fee contract to UAB, with a period of performance through June 30, 2018. The CARDIA study is a long-running longitudinal research effort focused on investigating cardiovascular disease development and risk factors in early adulthood....
- This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to the University of Alabama at Birmingham (UAB) for the Coronary Artery Risk Development in Young Adults (CARDIA) Study - Birmingham Field Center. The $7,699,918.00 cost-no-fee contract has a period of performance through June 30, 2034 and does not have a set-aside designation. UAB is a prominent public research university with extensive capabilities in biomedical research, clinical...
- This federal contract award with ID 75N92018D00007|75N92018F00001 was issued by the National Heart Lung and Blood Institute, a civilian agency, to the University of Alabama at Birmingham (UAB) as the prime contractor. The award is for the "CARDIA BIRMINGHAM FC - TASK AREA A" project with a period of performance from July 1, 2018 to June 30, 2019, and a ceiling value of $2,288,842.69. The contract is a delivery order with a cost no fee pricing type and is not set-aside. The CARDIA...
- The University of Alabama at Birmingham (UAB) was awarded a federal contract by the National Heart, Lung, and Blood Institute (NHLBI) for $7,967,653.41 to support the Coronary Artery Risk Development in Young Adults (CARDIA) study. The contract, which runs from July 2018 to June 2023, does not have a set-aside designation. As the prime contractor, UAB is responsible for various tasks including blood sample tracking and inventory, DNA extraction and distribution, data security, and freezer...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $72.0 million cost-no-fee definitive contract to the University of Alabama at Birmingham (UAB) on May 21, 2004, for operation of a field center supporting the Coronary Artery Risk Development in Young Adults (CARDIA) Study. This longitudinal epidemiological research initiative tracks cardiovascular risk factors and disease development in a cohort of young adults, with the Birmingham field center responsible for participant...
- This is a delivery order issued under the Coronary Artery Risk Development in Young Adults (CARDIA) study contract, which is administered by the National Heart, Lung, and Blood Institute (NHLBI). The University of Alabama at Birmingham (UAB) is the prime contractor, with several subcontractors including the University of Massachusetts Medical School, Solomon Park Research Laboratories, the Medical University of South Carolina, and the University of Minnesota. The total ceiling value of this...
- This is a definitive cost-no-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to the University of Alabama at Birmingham (UAB) for research and development facilities. The contract has a ceiling value of $51,806,163.19 and a completion date of December 31, 2008. UAB, a public research university and academic medical center, has extensive experience in federal contracting and grants, particularly in areas such as cancer...
- This is a definitive contract awarded by the U.S. government to the University of Alabama at Birmingham (UAB), a non-profit educational institution, on December 15, 2002. The contract has a firm fixed price of $1,497,441.00 and a completion date of June 30, 2007. There is no set-aside designation for this contract. UAB has an extensive track record of delivering biomedical and public health research under federal grant awards from agencies like the National Institutes of Health (NIH), Centers...
- The University of Alabama at Birmingham (UAB) was awarded a $42,411,498.54 Definitive Contract by the National Institute of Allergy and Infectious Diseases (NIAID) Division of Extramural Activities (DEA) for biomedical research and services. This is a Cost No Fee contract with an ultimate completion date of December 1, 2013. UAB has a strong track record of securing federal funding for biomedical research, including grants from the National Institutes of Health (NIH). The contract does not...
- This is a definitive federal contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to the University of Alabama at Birmingham (UAB), a non-profit educational institution. The contract, valued at $1,687,776.46, is for other ADP and telecommunications services. The contract does not have a set-aside designation. UAB has a strong track record of securing federal contracts and grants, including work for the Department of Defense, NASA, and the...